Udaya Stewart

• Led long range strategic planning to facilitate Executive and Board of Directors decision making around optimal capital allocation ($330M) within clinical programs and preclinical assets to extend cash runway.
• Managed OpEx of ~$160M annually to support 3 clinical programs and various pre-clinical assets, through budgeting, forecasting and variance analysis.
• Supported business development with valuation analysis to support ongoing external partnership negotiations.
• Key liaison between business planning, accounting, clinical operations, R&D program leadership, investor relations to ensure effective integration of financial planning and support.
• Owned corporate financial calendar and planning process to drive key financial deliverables.

Senior Finance Manager, R&D (09/2021 - 02/2023)

• Partnered with R&D program teams and external vendors (CROs etc.,) to develop program specific Long Range Plan , Annual Budget (AOP) and quarterly forecasts for ~$350M in spend.
• Led trial/program financial investment analysis (ROI, NPV etc.,) for various R&D Programs. This included coordinating clinical cost projections and preparing presentations for R&D Governance Council, R&D Leadership teams, and EC.
• Support R&D Leadership in annual planning, monthly variance analysis, board materials, CFO briefings and other ad hoc requests.

Senior Finance Manager, GBS (01/2020 - 09/2021); Finance Manager, GBS (07/2019 - 12/2020)

• Provided FP&A support to GBS for detailed AOP & LRP planning, including presentations for CFO review.
• Developed and published GBS's value delivery report to track project specific ~$120M savings target to stakeholders including EC and Finance Planners.
• Provided decision support and financial analysis (NPV,ROI etc) of various business cases as part of GBS shared service expansion.
• Standardizing savings definitions across Biogen for consistent reporting which included systems & training development in partnership with VP, Procurement and SVP, GBS.

• Managed a team of Sr. Financial Analysts responsible for developing and automating weekly & monthly KPIs on key cost drivers of logistics expenses to empower internal stakeholders.
• Developed and published a 5Q forecast model (AOP) supporting outbound logistics network of ~$700M to drive optimal margins.
• Piloted a strategic cost savings initiatives roadmap of $52 million in collaboration with supply chain operations, carrier strategy and customer service teams.

• Partnered with supply chain operations and accounting to complete month end close, variance analysis and provided logistics expense guidance to business units.
• Developed AOP/LRP (~$695M), updated monthly and weekly forecasts, while working closely with the operations team.
• Managed the weekly & monthly reporting of financial KPIs to support North America Supply Chain (SC) operations.
• Collaborated with supply chain operations and accounting in executing month-end close procedures, conducting thorough variance analysis, and offering strategic logistics expense guidance to business units.
• Spearheaded the development and maintenance of Annual Operating Plan/Long Range Plan (~$695M), consistently updating monthly and weekly forecasts, and closely aligning with the operations team. Orchestrated the efficient weekly and monthly reporting of financial Key Performance Indicators (KPIs) to bolster North America Supply Chain (SC) operations.

• Managed and mentored team of Analysts responsible for monthly close, weekly & monthly variance reports, and developing AOP.
• Led financial due diligence related to sale of Life Alive in Oct-15 for over $7M as well as post-close migration of all finance and accounting.

• Drove ~50% YoY revenue increase as a key team leader at Loupe during a growth phase, while offering expert guidance to high-growth startups in CFO office activities, specializing in financial systems, reporting, multi-year planning, budgeting, forecasting, and fundraising business cases.

• Analyzed and authored insight reports on various PE and VC funds and their portfolio companies to assess their performance and viability of investment decisions.